WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010031785) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GASTROINTESTINAL IRRITATION DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/031785    International Application No.:    PCT/EP2009/061997
Publication Date: 25.03.2010 International Filing Date: 16.09.2009
Chapter 2 Demand Filed:    29.03.2010    
IPC:
A61K 31/70 (2006.01), A61K 33/06 (2006.01), A61K 33/08 (2006.01), A61K 31/683 (2006.01), A61K 31/685 (2006.01), A61K 31/688 (2006.01)
Applicants: GIULIANI S.P.A. [IT/IT]; Via Palagi 2 I-20129 Milano (IT) (For All Designated States Except US).
BELLINVIA, Salvatore [IT/IT]; (IT) (For US Only).
MARTELLI, Laura [IT/IT]; (IT) (For US Only).
MARTELLI, Mario [IT/IT]; (IT) (For US Only)
Inventors: BELLINVIA, Salvatore; (IT).
MARTELLI, Laura; (IT).
MARTELLI, Mario; (IT)
Agent: APPOLONI, Romano; Notarbartolo & Gervasi S.p.A. Corso di Porta Vittoria 9 I-20122 Milan (IT)
Priority Data:
08425607.2 17.09.2008 EP
Title (EN) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GASTROINTESTINAL IRRITATION DISORDERS
(FR) COMPOSITION PHARMACEUTIQUE POUR TRAITEMENT DE TROUBLES D'IRRITATION GASTRO-INTESTINALE
Abstract: front page image
(EN)The invention relates to a pharmaceutical composition based on an active principle, such as primarily Sucralfate, for the treatment of disorders related to gastrointestinal irritation such as gastric ulcers, duodenal ulcers, acute gastritis, symptomatic chronic gastritis, gastropathy related to anti-inflammatories, reflux esophagitis, characterized by comprising one or more phospholipids. The invention relates to the use of phospholipids in combination with said active principle, to be administered orally for improving its palatability, and to the use of phospholipids in combination with said active principle to be administered orally for the treatment of gastrointestinal irritation disorders and to synergistically improve its anti-ulcer effect.
(FR)L'invention porte sur une composition pharmaceutique basée sur un principe actif, tel que principalement le sucralfate, pour traitement de troubles liés à l'irritation gastro-intestinale tels que des ulcères gastriques, des ulcères duodénaux, une gastrite aiguë, une gastrite chronique symptomatique, une gastropathie liée à des anti-inflammatoires, une œsophagite peptique, caractérisée par le fait qu'elle comprend un ou plusieurs phospholipides. L'invention porte sur l'utilisation de phospholipides en combinaison avec ledit principe actif, avec administration orale pour améliorer son caractère appétissant, et sur l'utilisation des phospholipides en combinaison avec ledit principe actif avec administration par voie orale pour le traitement de troubles d'irritation gastro-intestinale et pour améliorer de façon synergique son effet anti-ulcère.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)